COSCIENS Biopharma Inc. Rightofuse Assets
COSCIENS Biopharma Inc. (CSCIF) had Rightofuse Assets of $85.00 thousand as of 2022-09-30, per its 6-K filed 2022-11-03.
Discontinued › Notes
ifrs-full:RightofuseAssets · last filed 2022-11-03
- 2022-09-30: Rightofuse Assets $85.00K.
- 2022-06-30: Rightofuse Assets $114.00K.
- 2022-03-31: Rightofuse Assets $153.00K.
- 2021-12-31: Rightofuse Assets $150.00K.
| Period end | Rightofuse Assets |
|---|---|
| 2022-09-30 | $85.00K 6-K · filed 2022-11-03 |
| 2022-06-30 | $114.00K 6-K/A · filed 2022-08-04 |
| 2022-03-31 | $153.00K 6-K · filed 2022-05-11 |
| 2021-12-31 | $150.00K 6-K · filed 2022-11-03 |
| 2021-09-30 | $185.00K 6-K · filed 2021-11-04 |
| 2021-06-30 | $102.00K 6-K · filed 2021-08-05 |
| 2021-03-31 | $122.00K 6-K · filed 2021-05-05 |
| 2020-12-31 | $157.00K 20-F · filed 2022-03-29 |
| 2020-09-30 | $171.00K 6-K · filed 2020-11-05 |
| 2020-06-30 | $190.00K 6-K · filed 2020-08-06 |
| 2020-03-31 | $288.00K 6-K/A · filed 2020-05-11 |
| 2019-12-31 | $582.00K 40-F/A · filed 2021-03-29 |
| 2019-09-30 | $418.00K 6-K · filed 2019-11-07 |
| 2019-06-30 | $340.00K 6-K · filed 2019-08-13 |